Diabetes, Obesity and Metabolism

Cardiovascular effects of sulphonylureas: role of K_ATP channels
pp. 67-73(7)
Author: Howes L.G.

Hypoglycaemia and associated hypokalaemia in diabetes: mechanisms, clinical implications and prevention
pp. 75-82(8)
Authors: Heller S.R.; Robinson R.T.C.E.

The future of leptin and leptin analogues in the treatment of obesity
pp. 83-89(7)
Author: Bryson J.M.

Ethnicity and risk factors for coronary heart disease in diabetes mellitus
pp. 91-97(7)
Authors: Game F.L.; Jones A.F.

Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity
pp. 99-103(5)
Authors: Baranowska B.; Radzikowska M.; Wasilewska-Dziubinska E.; Roguski K.; Borowiec M.

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study
pp. 105-112(8)
Authors: Finer N.; Bloom S.R.; Frost G.S.; Banks L.M.; Griffiths J.

News and views
pp. 113-119(7)